Androgene und andere Hormone unter Buserelintherapie

Subscribe to RSS DOI: 10.1055/s-2007-1023690 Androgene und andere Hormone unter Buserelintherapie Androgens and Other Hormones during Buserelin TherapyPublication History Publication Date: 16 June 2008 (online) Zusammenfassung Das Nasenspray Buserelin wurde bei 23 Frauen im reproduktiven Alter zur Behandlung von laparoskopisch und bioptisch gesicherter Endometriose über 6 Monate eingesetzt und die hormonellen Veränderungen unter dieser Therapie nach 2, 4, 8,12,16, 20 und 24 Wochen erfaßt. LH, E2, Prolaktin, Progesteron und Testosteron nahmen signifikant während der Buserelintherapie ab. Die mittleren Serumspiegel für FSH, freies Testosteron, Androstendion senkten sich geringfügig. DHEAS und SHBG veränderten sich nicht. Buserelin hat keine androgenisierende Wirkung. Die Endometriose nahm - gemessen am Implantatscore - signifikant unter der Buserelintherapie ab. Abstract 23 women of reproductive age were treated with Buserelin nose-spray for endometriosis, which had been diagnosed by laparoscopic and bioptic methods. The treatment period was 6 months. Various hormones in serum were determined after 2, 4, 8,12,16, 20 and 24 weeks during treatment. LH, E2, prolactin, progesterone, and testosterone concentrations were significantly decreased under Buserelin therapy, whereas there was only a slight decrease in FSH, free testosterone and androstendion. No changes were observed in the concentrations of DHEAS and SHEBG. Buserelin had no androgenic effect. There was a significant decrease of endometriosis as judged by the implantation score.